Heterogeneity of CD4+ and CD8+ T cells

Current Opinion in Immunology

Volumn 15, Issue 3, 2003, Pages 336-342

  Woodland, David L ^a   Dutton, Richard W ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

BIODIVERSITY; CELL ASSAY; CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CELL POPULATION; CELLULAR DISTRIBUTION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HELPER CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; MEMORY CELL; NONHUMAN; PHENOTYPE; PLASTICITY; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 0038730996     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00037-2     Document Type: Review

References (92)

1. Swain S.L. T-cell subsets. Who does the polarizing? Curr. Biol. 5:1995;849-851.
2. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
3. Cerwenka A., Carter L.L., Reome J.B., Swain S.L., Dutton R.W. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J. Immunol. 161:1998;97-105.
4. Cerwenka A., Morgan T.M., Harmsen A.G., Dutton R.W. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 189:1999;423-434.
5. Mosmann T.R., Li L., Sad S. Functions of CD8 T-cell subsets secreting different cytokine patterns. Semin. Immunol. 9:1997;87-92.
6. Baumgarth N., Brown L., Jackson D., Kelso A. Novel features of the respiratory tract T-cell response to influenza virus infection: lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10. J. Virol. 68:1994;7575-7581.
7. + T cells from influenza immune mice concurrently produce in vitro IL2, IL4, and IFN-gamma. Cell Immunol. 170:1996;222-229.
8. + T cells. Annu. Rev. Immunol. 12:1994;635-673.
9. Wurster A.L., Rodgers V.L., Satoskar A.R., Whitters M.J., Young D.A., Collins M., Grusby M.J. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J. Exp. Med. 196:2002;969-977.
10. Smeltz R.B., Chen J., Ehrhardt R., Shevach E.M. Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor beta 2 expression. J. Immunol. 168:2002;6165-6172.
11. Swain S.L. Interleukin 18: tipping the balance towards a T helper cell 1 response. J. Exp. Med. 194:2001;11-14.
12. Zhang Y., Apilado R., Coleman J., Ben-Sasson S., Tsang S., Hu-Li J., Paul W.E., Huang H. Interferon gamma stabilizes the T helper cell type 1 phenotype. J. Exp. Med. 194:2001;165-172.
13. Wang X., Mosmann T. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells. J. Exp. Med. 194:2001;1069-1080.
14. Ahmadzadeh M., Farber D.L. Functional plasticity of an antigen-specific memory CD4 T cell population. Proc. Natl. Acad. Sci. U.S.A. 99:2002;11802-11807.
15. + T cells can be distinguished by their cytokine profiles and phenotypic markers. J. Immunol. 164:2000;208-216.
16. Thompson A.H., London L., London S.D. Heterogeneous cytokine production by acutely stimulated bronchoalveolar T lymphocytes in reovirus 1/Lang-infected mice. Cell Immunol. 198:1999;120-130.
17. + T lymphocytes. J. Immunol. 167:2001;181-187.
18. + T cell populations. Int. Immunol. 11:1999;617-621.
19. Wu C.Y., Kirman J.R., Rotte M.J., Davey D.F., Perfetto S.P., Rhee E.G., Freidag B.L., Hill B.J., Douek D.C., Seder R.A. Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo. Nat. Immunol. 3:2002;852-858 This paper suggests that memory cells arise preferentially from cells that have not secreted IFN-γ. It will be interesting to see whether this theory is true in general.
20. Campbell D.J., Kim C.H., Butcher E.C. Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat. Immunol. 2:2001;876-881.
21. Suni M.A., Ghanekar S.A., Houck D.W., Maecker H.T., Wormsley S.B., Picker L.J., Moss R.B., Maino V.C. CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens. Eur. J. Immunol. 31:2001;2512-2520.
22. + CTLs ex vivo. J. Immunol. 168:2002;5954-5958.
23. + T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:2000;63-75.
24. Lieberman J., Shankar P., Manjunath N., Andersson J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood. 98:2001;1667-1677.
25. Lee P.P., Yee C., Savage P.A., Fong L., Brockstedt D., Weber J.S., Johnson D., Swetter S., Thompson J., Greenberg P.D.et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5:1999;677-685.
26. + T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells. J. Exp. Med. 193:2001;595-606 Together with [27], this paper provides examples of incomplete effector development in response to a viral antigen.
27. Zajac A.J., Blattman J.N., Murali-Krishna K., Sourdive D.J., Suresh M., Altman J.D., Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:1998;2205-2213.
28. + T-cell response to Epstein-Barr virus (EBV): implications for the pathogenesis of EBV-associated lymphoproliferative disorders. Blood. 91:1998;3875-3883.
29. Powell J.D., Ragheb J.A., Kitagawa-Sakakida S., Schwartz R.H. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy. Immunol. Rev. 165:1998;287-300.
30. + T cells can persist and function in vivo. J. Immunol. 163:1999;155-164.
31. + T-cell memory is induced by Sendai virus infection of mice. J. Virol. 73:1999;7278-7286.
32. Ahmadzadeh M., Hussain S.F., Farber D.L. Heterogeneity of the memory CD4 T cell response: persisting effectors and resting memory T cells. J. Immunol. 166:2001;926-935.
33. •] are examples in which T cells respond to stimulation with a self antigen, but do not mature into cells with normal effector function.
34. •] are examples in which T cells respond to stimulation with a self antigen, but do not mature to a state in which they express normal effector function.
35. Blohm U., Roth E., Brommer K., Dumrese T., Rosenthal F.M., Pircher H. Lack of effector cell function and altered tetramer binding of tumor-infiltrating lymphocytes. J. Immunol. 169:2002;5522-5530.
36. Nelson D.J., Mukherjee S., Bundell C., Fisher S., van Hagen D., Robinson B. Tumor progression despite efficient tumor antigen cross-presentation and effective 'arming' of tumor antigen-specific CTL. J. Immunol. 166:2001;5557-5566 This provides yet another example in which T cells have responded but fail to attack the antigen - in this case a tumor cell.
37. Gonzalez M., Quezada S.A., Blazar B.R., Panoskaltsis-Mortari A., Rudensky A.Y., Noelle R.J. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning. J. Immunol. 169:2002;5581-5589.
38. Pantaleo G., Demarest J.F., Schacker T., Vaccarezza M., Cohen O.J., Daucher M., Graziosi C., Schnittman S.S., Quinn T.C., Shaw G.M.et al. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl. Acad. Sci. U.S.A. 94:1997;254-258.
39. + T cells to death. Trends Microbiol. 1:1993;207-209.
40. Gallimore A., Glithero A., Godkin A., Tissot A.C., Pluckthun A., Elliott T., Hengartner H., Zinkernagel R. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1998;1383-1393.
41. Moskophidis D., Lechner F., Pircher H., Zinkernagel R.M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature. 362:1993;758-761.
42. + T cells. J. Immunol. 168:2002;5933-5942.
43. + T cells persist in most peripheral organs and retain various effector functions.
44. Lefrancois L., Masopust D. T cell immunity in lymphoid and non-lymphoid tissues. Curr. Opin. Immunol. 14:2002;503-508.
45. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:1999;708-712.
46. Sallusto F., Langenkamp A., Geginat J., Lanzavecchia A. Functional subsets of memory T cells identified by CCR7 expression. Curr. Top Microbiol. Immunol. 251:2000;167-171.
47. Aandahl EI, Sandberg JK, Beckerman KP, Tasken K, Moretto WJ, Nixon DF: CD7 is a differentiation marker that identifies multiple CD8 T-cell effector subsets. J Immunol 2003, in press.
48. + T cells persist in the lung airways for over a year following recovery from a primary influenza or Sendai virus infection.
49. + memory T cells in nonlymphoid tissues express a highly activated phenotype. J. Immunol. 169:2002;6655-6658.
50. Lefrancois L. Dual personality of memory T cells. Trends Immunol. 23:2002;226-228.
51. + T cells in the lung airways depends on proliferation. J. Immunol. 169:2002;4976-4981.
52. + T cell responses. Nat. Immunol. 3:2002;189-195 In this paper, and the next two papers [53,54] the authors demonstrate that members of an additional family of receptor-ligand interactions can modify effector cell function.
53. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., Lanier L.L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 12:2000;721-727.
54. +) T cells. J. Immunol. 169:2002;1444-1452.
55. Dutton R.W., Bradley L.M., Swain S.L. T cell memory. Annu. Rev. Immunol. 16:1998;201-223.
56. Ahmed R., Gray D. Immunological memory and protective immunity: understanding their relation. Science. 272:1996;54-60.
57. + T-cell response to influenza virus infection using adoptively transferred TCR transgenic T cells specific for an influenza virus hemagglutinin peptide. The data show that naïve T cells undergo extensive proliferation in local draining lymph nodes before acquiring full effector function and the capacity to migrate to the lung.
58. Sallusto F., Kremmer E., Palermo B., Hoy A., Ponath P., Qin S., Forster R., Lipp M., Lanzavecchia A. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29:1999;2037-2045.
59. Swain S.L. Helper T cell differentiation. Curr. Opin. Immunol. 11:1999;180-185.
60. + T cells during viral infection. J. Immunol. 166:2001;795-799.
61. Campbell D.J., Butcher E.C. Intestinal attraction: CCL25 functions in effector lymphocyte recruitment to the small intestine. J. Clin. Invest. 110:2002;1079-1081.
62. Lanzavecchia A., Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science. 290:2000;92-97.
63. + T cells. J. Immunol. 168:2002;1723-1729.
64. Bird J.J., Brown D.R., Mullen A.C., Moskowitz N.H., Mahowald M.A., Sider J.R., Gajewski T.F., Wang C.R., Reiner S.L. Helper T cell differentiation is controlled by the cell cycle. Immunity. 9:1998;229-237.
65. Opferman J.T., Ober B.T., Ashton-Rickardt P.G. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science. 283:1999;1745-1748.
66. Liang L., Sha W.C. The right place at the right time: novel B7 family members regulate effector T cell responses. Curr. Opin. Immunol. 14:2002;384-390.
67. Greenwald R.J., Latchman Y.E., Sharpe A.H. Negative co-receptors on lymphocytes. Curr. Opin. Immunol. 14:2002;391-396.
68. Fecteau S., Basadonna G.P., Freitas A., Ariyan C., Sayegh M.H., Rothstein D.M. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat. Immunol. 2:2001;58-63.
69. Gilfillan M.C., Noel P.J., Podack E.R., Reiner S.L., Thompson C.B. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines. J. Immunol. 160:1998;2180-2187.
70. + T cells by skin grafts via direct antigen presentation. J. Immunol. 169:2002;1270-1276.
71. Weinberg A.D., Wegmann K.W., Funatake C., Whitham R.H. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J. Immunol. 162:1999;1818-1826.
72. Wen T., Bukczynski J., Watts T.H. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function. J. Immunol. 168:2002;4897-4906.
73. Sepulveda H., Cerwenka A., Morgan T., Dutton R.W. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. J. Immunol. 163:1999;1133-1142.
74. Boissonnas A., Bonduelle O., Lucas B., Debre P., Autran B., Combadiere B. Differential requirement of caspases during naive T cell proliferation. Eur. J. Immunol. 32:2002;3007-3015.
75. Tham E.L., Mescher M.F. The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness). J. Immunol. 169:2002;1822-1828.
76. Vivier E., Tomasello E., Paul P. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Curr. Opin. Immunol. 14:2002;306-311.
77. Coyle A.J., Gutierrez-Ramos J.C. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2:2001;203-209.
78. Zhou S., Ou R., Huang L., Moskophidis D. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection. J. Virol. 76:2002;829-840.
79. Matloubian M., Suresh M., Glass A., Galvan M., Chow K., Whitmire J.K., Walsh C.M., Clark W.R., Ahmed R. A role for perforin in downregulating T-cell responses during chronic viral infection. J. Virol. 73:1999;2527-2536.
80. Refaeli Y., Van Parijs L., Alexander S.I., Abbas A.K. Interferon gamma is required for activation-induced death of T lymphocytes. J. Exp. Med. 196:2002;999-1005.
81. Dalton D.K., Haynes L., Chu C.Q., Swain S.L., Wittmer S. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J. Exp. Med. 192:2000;117-122.
82. Turley S.J. Dendritic cells: inciting and inhibiting autoimmunity. Curr. Opin. Immunol. 14:2002;765-770.
83. + suppressor T cells. J. Exp. Med. 193:2001;41-46.
84. Lanzavecchia A., Sallusto F. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 13:2001;291-298.
85. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:1997;737-742.
86. Welsh R.M. Assessing CD8 T cell number and dysfunction in the presence of antigen. J. Exp. Med. 193:2001;19-22.
87. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, Antia R, Von Andrian UH, Ahmed R: Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003 (published online 3rd February 2003) DOI: 10.1038/ni889.
88. Geginat J., Sallusto F., Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naïve, central memory, and effector memory CD4(+) T cells. J. Exp. Med. 194:2001;1711-1719.
89. + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003, (published online 6th February 2003) DOI: 10.1182/blood-2002-11-3577.
90. + central and effector T cell subsets are largely distinct. Immunity. 18:2003;193-204.
91. Janssen E.M., Lemmens E.E., Wolfe T., Christen U., Von Herrath M.G., Schoenberger S.P. CD4(+) T cells are required for secondary expansion and memory in CD8(+) T lymphocytes. Nature. 421:2003;852-856.
92. Shedlock D.J., Whitmire J.K., Tan J., MacDonald A.S., Ahmed R., Shen H. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection. J. Immunol. 170:2003;2053-2063.